StonvexLoading…
StonvexStonvexStonvexCore line items from AVAH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|---|
Revenue | $641.30M | $647.91M | $2.43B | $1.77B | $1.15B |
Operating Income | Not available | $69.33M | $256.46M | $185.42M | $131.84M |
Net Income | Not available | $41.65M | $225.03M | $46.28M | $32.22M |
EPS (Diluted) | $0.17 | $0.19 | $1.05 | $0.22 | $0.16 |
Total Assets | Not available | $2.02B | $2.01B | $1.81B | $1.77B |
Total Liabilities | Not available | $1.78B | $1.82B | $1.80B | $1.78B |
Cash & Equivalents | Not available | $189.27M | $193.26M | $145.87M | $100.74M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 217.51M | 211.00M | 208.91M | 208.26M |